Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

oral targeted therapy found to be an effective treatment option for high risk hairy cell leukemia

Sumary of Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia:

  • The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G.
  • Hairy cell leukemia is a rare form of B-cell blood cancer that is diagnosed in 600 to 800 people annually in the United States.
  • There is a critical unmet need for therapy options in this subset of patients to achieve long-term cancer control.
  • however, ibrutinib is FDA approved for the treatment of certain cancers, including mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma and others.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close